SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-109284
Filing Date
2020-04-16
Accepted
2020-04-16 16:02:04
Documents
9
Period of Report
2020-05-28
Effectiveness Date
2020-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d859939ddef14a.htm DEF 14A 865568
2 GRAPHIC g859939g06e08.jpg GRAPHIC 92017
3 GRAPHIC g859939g11y77.jpg GRAPHIC 26592
4 GRAPHIC g859939g18r02.jpg GRAPHIC 8555
5 GRAPHIC g859939g21j11.jpg GRAPHIC 24658
6 GRAPHIC g859939g32p61.jpg GRAPHIC 25201
7 GRAPHIC g859939g39a39.jpg GRAPHIC 112862
8 GRAPHIC g859939g56z83.jpg GRAPHIC 16586
9 GRAPHIC g859939g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-20-109284.txt   1320772
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36014 | Film No.: 20796376
SIC: 2834 Pharmaceutical Preparations